Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Panciroli

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 31, 2019
Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumabC Panciroli, G Lucente, L Vidal, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 9, 2018
Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patientsC Balaña, A Estival, I Teruel, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 31, 2019
Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumabC Panciroli, G Lucente, L Vidal, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 9, 2018
Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patientsC Balaña, A Estival, I Teruel, et al.
Pageof 3